Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
14.71
-0.11 (-0.74%)
May 30, 2025, 3:04 PM CST
SHE:300401 Revenue
Zhejiang Garden Biopharmaceutical had revenue of 326.39M CNY in the quarter ending March 31, 2025, a decrease of -1.18%. This brings the company's revenue in the last twelve months to 1.24B, up 11.88% year-over-year. In the year 2024, Zhejiang Garden Biopharmaceutical had annual revenue of 1.24B with 13.58% growth.
Revenue (ttm)
1.24B
Revenue Growth
+11.88%
P/S Ratio
6.45
Revenue / Employee
1.21M
Employees
1,021
Market Cap
7.99B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.24B | 148.63M | 13.58% |
Dec 31, 2023 | 1.09B | -322.86M | -22.78% |
Jan 1, 2023 | 1.42B | 300.41M | 26.89% |
Jan 1, 2022 | 1.12B | 457.66M | 69.40% |
Dec 31, 2020 | 659.44M | -58.95M | -8.21% |
Dec 31, 2019 | Pro | Pro | Pro |
Jan 1, 2019 | Pro | Pro | Pro |
Jan 1, 2018 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |